Adastra Holdings Enters into Agreements to Sell Subsidiaries
Adastra Holdings (OTC: XTXXF) announced agreements dated October 8, 2025 to sell three wholly owned subsidiaries for an aggregate consideration of $4,000,000. The consideration includes a $495,000 12% interest-bearing promissory note for Adastra Labs, $3,500,000 satisfied by purchaser assumption of the existing mortgage on 1178562's Langley, BC property, and $5,000 cash for Adastra Brands.
Related agreements include a leaseback: 1178562 will lease 13,000 sq ft to Adastra Labs Inc. for $35,000 per month, and an intellectual property license from Adastra Brands to the company for nominal consideration. The company said the transactions aim to strengthen the balance sheet, reduce debt, and streamline operations; closing remains subject to customary conditions.
Adastra Holdings (OTC: XTXXF) ha annunciato accordi datati 8 ottobre 2025 per la vendita di tre controllate interamente di proprietà per un controvalore complessivo di $4,000,000. La contropartita comprende una nota promissoria a interesse del 12% per $495,000 destinata ad Adastra Labs, $3,500,000 soddisfatta dall'assunzione da parte dell'acquirente dell'ipoteca esistente sulla proprietà di Langley, BC di 1178562, e $5,000 in contanti per Adastra Brands.
Gli accordi correlati includono una ri-leaseback: 1178562 affitterà 13,000 sq ft a Adastra Labs Inc. per $35,000 al mese, e una licenza di proprietà intellettuale da Adastra Brands alla società per una somma simbolica. L'azienda ha detto che le transazioni mirano a rafforzare il bilancio, ridurre il debito e semplificare le operazioni; la chiusura resta soggetta a condizioni usuali.
Adastra Holdings (OTC: XTXXF) anunció acuerdos con fecha 8 de octubre de 2025 para vender tres subsidiarias de propiedad total por una contraprestación total de $4,000,000. La contraprestación incluye una promesa de pago con interés del 12% por $495,000 para Adastra Labs, $3,500,000 satisfecha por la asunción por parte del comprador de la hipoteca existente sobre la propiedad de Langley, BC de 1178562, y $5,000 en efectivo para Adastra Brands.
Los acuerdos relacionados incluyen una venta con arrendamiento posterior: 1178562 arrendara 13,000 sq ft a Adastra Labs Inc. por $35,000 al mes, y una licencia de propiedad intelectual de Adastra Brands a la empresa por una contraprestación nominal. La empresa indicó que las transacciones buscan fortalecer el balance, reducir la deuda y simplificar las operaciones; el cierre continúa sujeto a condiciones habituales.
Adastra Holdings (OTC: XTXXF)은 2025년 10월 8일자로 서명된 계약을 발표했다. 총 $4,000,000의 대가로 세 개의 전액 소유 자회사를 매각한다는 내용이다. 대가는 Adastra Labs를 위한 12% 이자 약정어음 $495,000, 1178562의 Langley, BC 자산에 대한 기존 모기지 인수를 매수자가 인수하는 형식으로 달성되는 $3,500,000, 그리고 Adastra Brands에 대한 현금 $5,000로 구성된다.
관련 계약에는 매각 후 리스가 포함된다: 1178562가 Adastra Labs Inc.에 대해 13,000 sq ft를 월 $35,000에 임대하고, Adastra Brands로부터 회사에 무상 상당의 지적 재산권 라이선스가 주어진다. 회사는 이 거래들이 재무상태표를 강화하고 부채를 줄이며 운영을 간소화하기 위한 것이라고 밝혔다. 마감은 일반적인 조건에 따른다.
Adastra Holdings (OTC: XTXXF) a annoncé des accords datés du 8 octobre 2025 pour la vente de trois filiales entièrement détenues pour une contrepartie globale de $4,000,000. La contrepartie comprend une promesse de prêt portant intérêt à 12% pour $495,000 destinée à Adastra Labs, $3,500,000 satisfaite par l'acquéreur via l'absorption de l'hypothèque existante sur la propriété de Langley, BC de 1178562, et $5,000 en espèces pour Adastra Brands.
Les accords connexes incluent un bail-back: 1178562 louera 13,000 sq ft à Adastra Labs Inc. pour $35,000 par mois, et une licence de propriété intellectuelle d'Adastra Brands à la société pour une contrepartie nominale. La société indique que les transactions visent à renforcer le bilan, réduire la dette et rationaliser les opérations; la clôture reste soumise à des conditions habituelles.
Adastra Holdings (OTC: XTXXF) kündigte Vereinbarungen vom 8. Oktober 2025 an, drei vollständig eigenständige Tochtergesellschaften für eine Gesamtentschädigung von $4,000,000 zu verkaufen. Die Gegenleistung umfasst eine 12%-ige zinsbringende Vorschussschuld über $495,000 für Adastra Labs, $3,500,000, die durch die Übernahme der bestehenden Hypothek auf das Grundstück von Langley, BC von 1178562 durch den Käufer beglichen wird, und $5,000 in bar für Adastra Brands.
Zu den verwandten Vereinbarungen gehört ein Back-to-Back-Mietvertrag: 1178562 wird 13,000 sq ft an Adastra Labs Inc. für $35,000 pro Monat vermieten, sowie eine immaterielle Eigentumsrechtslizenz von Adastra Brands an das Unternehmen gegen eine symbolische Gegenleistung. Das Unternehmen sagte, die Transaktionen zielen darauf ab, die Bilanz zu stärken, Schulden zu reduzieren und die Geschäfte zu straffen; der Abschluss bleibt unter üblichen Bedingungen vorbehalten.
Adastra Holdings (OTC: XTXXF) أعلن عن اتفاقيات بتاريخ 8 أكتوبر 2025 لبيع ثلاث شركات تابعة مملوكة بالكامل مقابل عوض إجمالي قدره $4,000,000. يشمل المقابل سنداً ووعداً بالدفع بفائدة 12% لـ $495,000 لـ Adastra Labs، و$3,500,000 يتم تسديدها بتحمل المشتري الرهن العقاري الموجود على عقار Langley، BC لـ 1178562، و$5,000 نقداً لـ Adastra Brands.
تشمل الاتفاقيات المرتبطة أيضاً اتفاقاً لإعادة الإيجار: ستؤجر 1178562 لـ Adastra Labs Inc. 13,000 قدم مربع مقابل $35,000 شهرياً، ورخصة ملكية فكرية من Adastra Brands إلى الشركة مقابل عوض رمزي. قالت الشركة إن صفقات التحويل تهدف إلى تقوية الميزانية وتقليل الدين وتبسيط العمليات؛ الإغلاق يظل خاضعاً للظروف المعتادة.
Adastra Holdings (OTC: XTXXF) 宣布于2025年10月8日签署的协议，以总额 $4,000,000出售三家全资子公司。对价包括一张面向 Adastra Labs、利率为12%的本息票据，金额为 $495,000；$3,500,000通过买方承担现有的 Langley, BC 的第1178562号物业抵押来清偿；以及 $5,000 的现金用于 Adastra Brands。
相关协议还包括回租：1178562 将向 Adastra Labs Inc. 出租 13,000 sq ft，月租金为 $35,000；同时 Adastra Brands 向该公司授予一项知识产权许可，代价为象征性对价。公司表示，这些交易旨在加强资产负债表、降低债务并简化运营；成交尚需符合通常条件方可完成。
- Aggregate proceeds of $4,000,000
- Mortgage assumption of $3,500,000 removes lender obligation
- Leaseback secures continued use of 13,000 sq ft facility
- $495,000 promissory note bears 12% interest
- New lease creates $35,000 monthly cash outflow
- Completion remains subject to customary closing conditions
Langley, British Columbia--(Newsfile Corp. - October 8, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has entered into agreements to sell all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("1178562"), and Adastra Brands Inc. ("Adastra Brands").
The aggregate consideration for all transactions is
In connection with the share purchase agreements, 1178562 and the Company's wholly owned subsidiary, Adastra Labs Inc., agreed to enter into a lease agreement pursuant to which 1178562 will lease 13,000 square feet of warehouse and office space located at the Property to Adastra Labs Inc. in consideration for
The sale of the Company's subsidiaries aligns with the Company's strategy to strengthen its balance sheet, reduce debt, and streamline operations. Through the related leaseback and intellectual property licensing agreements entered into in connection with the transactions, the Company is in a position to continue to operate from its existing facility and retain the right to use its established brands and trademarks.
The transactions are expected to be completed shortly and remain subject to customary closing conditions.
About Adastra Holdings Ltd.
Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: www.adastraholdings.ca.
For additional information, please contact:
Jonathan Edwards, CFO
(778) 715-5011
info@adastraholdings.ca
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "expected," "anticipated," "will," or similar expressions. Forward-looking statements in this press release include but are not limited to the Company or its subsidiaries entering into a lease agreement and intellectual property licensing agreement, the Company strengthening its balance sheet, reducing debt, and streamlining operations, the Company continuing to operate from its existing facility and retaining the right to use its established brands and trademarks, the transactions completing shortly. These forward-looking statements are made as of the date of this press release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors include, among others, the ability to satisfy customary closing conditions and obtain any necessary regulatory approvals. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
The Canadian Securities Exchange has not reviewed this press release and does not accept responsibility for the adequacy or accuracy of this news release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/269777
FAQ
What subsidiaries did Adastra Holdings (XTXXF) agree to sell on October 8, 2025?
How much is Adastra Holdings (XTXXF) receiving for the subsidiary sales?
What are the payment details for the Adastra Labs sale under XTXXF?
How is the $3,500,000 portion of the XTXXF transactions being satisfied?
Will Adastra (XTXXF) continue operating at the Langley facility after the sales?
What happens to Adastra's trademarks after the sale under XTXXF?
Are the subsidiary sale transactions for XTXXF final?
